VERA - Latest News
Vera Therapeutics, Inc. (VERA), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $3.05B. Beta to the broader market is 0.95.
The article list below shows the most recent VERA headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent VERA Headlines
3 Biotech Firms With Major Potential Catalysts in the Coming Months
marketbeat.com - Jun 23, 2026
As Big Pharma braces for a looming patent cliff that threatens billions in revenue, a different group of companies is chasing the opposite story: a si
3 Biotech Firms With Major Potential Catalysts in the Coming Months
marketbeat.com - Jun 21, 2026
As Big Pharma braces for a looming patent cliff that threatens billions in revenue, a different group of companies is chasing the opposite story: a si
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com - Jun 5, 2026
BRISBANE, Calif. , June 05, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc.
$20 Billion: Inside Nvidia's VERA CPU Bet to Break the Intel-AMD Duopoly
247wallst.com - Jun 4, 2026
You can argue about almost every line in a NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) earnings release.
Vera Therapeutics Announces Alignment with U.S. FDA on Earlier ORIGIN Phase 3 Analysis to Support Potential Full Approval for Atacicept in Adults with IgA Nephropathy
globenewswire.com - Jun 2, 2026
Vera Therapeutics Announces Alignment with U. S.
How News Affects VERA Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track VERA's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked VERA news questions
- What is the latest VERA news headline?
- The most recent VERA headline (Jun 23, 2026) is "3 Biotech Firms With Major Potential Catalysts in the Coming Months". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the VERA news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What VERA news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual VERA options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.